🇺🇸 FDA

Intelligence Platform

Patents

Browse 61 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8431615

Dose forms

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415332

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Teva Womans's Health, Inc. · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288342

Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low do

TEVA WOMEN'S HEALTH, INC. · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273746

Methods involving aldose reductase inhibitors

The Board of Regents of the University of Texas System · Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and

Ludwig-Maximilians-Universitat Munchen · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579006

Method of treating immune pathologies with low dose estrogen

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7481212

Increased dosage metered dose inhaler

Nektar Therapeutics · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371385

Method of treating immune pathologies with low dose estrogen

Government of the United states of America dba The Department of Veterans Affairs · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6696407

Huntington's disease treatment comprising administering aldose reductase inhibitors to inc

The Regents of the University of California · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6692763

Methods for treating postmenopausal women using ultra-low doses of estrogen

The Regents of the University of California · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6638495

Stabilized preparation for use in metered dose inhalers

Nektar Therapeutics · Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6251362

Method of establishing the optimal radiation dose

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6022521

Method of establishing the optimal radiation dose for radiopharmaceutical treatment of dis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired